Journals / Türk Fertilite Dergisi / 2002 / Cilt: 10 - Sayı: 1

The effects of 3 different hormone replacement therapies on vaginal mucosa

Postmenopozal kadınlarda 3 farklı hormon tedavisinin vajinal mukoza üzerine etkisi

Pages
86–91
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Tibolone has similar effects with 17-ß estradiol and 17-ß estradiol l N ETA on vaginal mucosa.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To compare the effects of tibolone with 17-ß estradiol and 17-ß estradiol /NETA on vaginal mucosa.
📊
Key Findings & Data:Study design: 45 post menopausal women were evaluated before hormone replacement therapy and 3 months of treatment. 15 women received 17ß estradiol, 15 women were treated with 17 ß estradiol /NETA and 15 women received tibolone.
💡
Conclusion & Impact:Conclusion: Tibolone has similar effects with 17-ß estradiol and 17-ß estradiol l N ETA on vaginal mucosa.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To compare the effects of tibolone with 17-ß estradiol and 17-ß estradiol /NETA on vaginal mucosa. Study design: 45 post menopausal women were evaluated before hormone replacement therapy and 3 months of treatment. 15 women received 17ß estradiol, 15 women were treated with 17 ß estradiol /NETA and 15 women received tibolone. The effectiveness of the therapies were evaluated with gynecological examinations which included assessments of vaginal pH. vaginal cytology (karyopicnotic index and maturation value). Results: There was a statistical significance between pretreatment and post treatment groups for vaginal pH and cytology, the effectiveness of treatment between groups were not different. Conclusion: Tibolone has similar effects with 17-ß estradiol and 17-ß estradiol l N ETA on vaginal mucosa.

Özet

Amaç: Bu çalışmada tibolonun vajinal mukoza üzerindeki etkileri 17-ß estradiol ve 17-ß estradiol INETA ile karalaştırılmıştır. Materyal ve Metod: 2001-2002 yıllan arasında daha önce hiç hormon replasman tedavisi almamış 45 postmenopozal kadına 3 ay süre ile farklı tedaviler (15 hastaya 17-ß estradiol. 15 hastaya da 17-ß estradiol /INETA, 15 hastaya tibolone) verildi. Tedavilerin etkinliği pH ölçümü, vajinal sitoloji değerlendirilmesi (karyopiknotik indeks ve maturasyon değeri) ile yapıldı. Bulgular: Her 3 tedavi sonrasında vajinal pH belirgin azalırken, karyopiknotik indeks ve maturasyon değerlerinde artma saptanmıştır. Gruplar arasında bu etkiler açısından istatistiksel olarak belirgin fark saptanmamıştır. Sonuç: Tibolonun vajinal mukoza üzerindeki etkileri 17-ß estradiol ve 17-ß estradiol /NETA ile benzerdir.

🔖

Cite This Article

TARIM, E., KUŞÇU, E., BAĞIŞ, T., KIYICI, H., KUILLICADAĞ, B., ERKANLI, S. (2022). The effects of 3 different hormone replacement therapies on vaginal mucosa. Türk Fertilite Dergisi, Cilt: 10 - Sayı: 1, 86–91. https://ajindex.com/articles/623391

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. A.Stenberg, G.Heimer, U. Ulmsten. The prevalence of urogenital symptoms in postmenopausal women. Maturitas 22 Suppl.J995; 17-20
  2. Kaufman RH, Friedrich EG, Gardner HL. Benign diseases of the vulva and the vagina. Chicago:YearBook Medical Publisher;1989.p 419-24
  3. Kicovic PM, Cortes-Prieto J, Milojevic S, Haspels AA. The treatment of postmenopausal vaginal atrophy with ov estin vaginal cream or suppositories: clinical, endocrinological and safety aspects. Maturitas 1996;23:259-63
  4. Heimer GM, EnglundDE. Effects of vaginally administered oestriol on post menopausal urogenital disorders:a cytohormonal study.Maturitas 1992;14:171-9
  5. Notelovitz M. Estrogen therapy in the management of problems associated with urogenital ageing:A simple diagnostic test and the effect of the route of hormone administiration. Maturitas 1995;22:31-3
  6. Lindsay R, Hart DmMcK, Kraszewski A. Pros¬pective double blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis. Br MedJ 1980; 1207-9
  7. Farish E, Fletcher CD, Hart DM, Lindsay R. Org OD 14: Long term effects on serum lipoproteins. Maturitas 1984;6:197-9
  8. Cortes Prieto J. Coagulation and fibrinolysis in postmenopausal women treated with Org OD 14. Maturitas 1987; Suppl,1:67-72
  9. Rymer J, Chapman MG, Fogelman I, Wilson PO.A study of the effect of tibolone on the vagina in postmenopausal women. Maturitas 1994;18(2):127-33
  10. Mishell DR. Menopause: Physiology and Pharmacology, Chicago: Yearbook Medical Publishers, 1987
  11. Semmens J, Tsai C, Curtis E, Loadholt C. Effects of estrogen therapy on vaginal physiology during menopause. Obstet Gynecol 1985;66:15-18
  12. Şener B, Oğuz S, Kutlay L, Yalçın H. Cytological effects of transdermal and oral estrogen therapy on vaginal mucosa. Gynecol Obstet Reprod Med 2002;8:37-41
  13. Volpe A, Facchinetti F, Grasso A, Petraglia F,Campanini D. Benefits and risks of different hormonal replacement therapies in. postmenopausal women.Maturitas 1986;8:327-34
  14. De Aloysio D, Fabiani AG, Mauloni M. Use of Org OD14fer the treatment of climacteric complaints.Maturitas 1987; Suppl 1:49-65.